Experimental Drug Tolinapant Boosts Immunotherapy Response in Advanced Solid Tumors
A phase I trial found that the IAP antagonist tolinapant combined with pembrolizumab was well tolerated and produced a 33 ...
Tag: ER-positive breast cancer
Tiny Blood-Borne Vesicles Carry Cytokine Clues to ER-Positive Breast Cancer and Its Treatment Response
Norwegian researchers report that cytokines carried on blood-borne extracellular vesicles distinguish ER-positive breast cancer patients from healthy individuals and shift ...
Targeting ESR1 Reactivates Autophagy, Boosts Breast Cancer Sensitivity
In a groundbreaking advance that could reshape the therapeutic landscape for estrogen receptor-positive (ER-positive) breast cancer, researchers have unraveled a ...
POPULAR NEWS
-
Talar Cartilage Lesions Linked to Impaired Balance and Reduced Foot Vibration Perception
-
Bedside Hypothesis-Driven History Teaching Sharpens Reasoning but Raises Assessment Concerns
-
Exploratory Laboratory Model Shows Modest Predictive Value for Bile Duct Cancer Invasion
-
Solar Panels Alter Desert Soil Microbial Networks Across Depth Profiles